Company Filing History:
Years Active: 2015
Title: Juan Morote Robles: Innovator in Prostate Cancer Prognosis
Introduction
Juan Morote Robles is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medical technology, particularly in the area of prostate cancer prognosis. His innovative work focuses on utilizing genetic variations to improve patient outcomes following prostatectomy.
Latest Patents
Juan Morote Robles holds 1 patent for a prognostic method aimed at predicting the recurrence of prostate cancer (PCa) in patients after prostatectomy. This method leverages the outcomes of selected single nucleotide polymorphisms (SNPs) alongside clinical variables. Additionally, he has developed a method for genotyping PCa-associated genetic variations, which includes the use of a DNA microarray. His patent also encompasses a microarray designed for use in these described methods.
Career Highlights
Throughout his career, Juan has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Progenika Biopharma S.A. and Juste S.A.Q.F. His work in these organizations has contributed to advancements in genetic research and cancer prognosis.
Collaborations
Juan has collaborated with esteemed colleagues, including Jokin Del Amo and Diego Tejedor Hernández. Their joint efforts have furthered the understanding and application of genetic factors in cancer treatment.
Conclusion
Juan Morote Robles stands out as an innovator in the field of prostate cancer prognosis, with a focus on genetic variations that can significantly impact patient care. His contributions are paving the way for more effective prognostic methods in oncology.